Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Recombinant DNA01:09

Recombinant DNA

Overview
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
The Central Dogma01:20

The Central Dogma

The central dogma explains the flow of genetic information from DNA nucleotides to the amino acid sequence of proteins.
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CO<sub>2</sub>-Activated Starch-Derived Hierarchically Porous Carbon for High-Performance Zinc-Ion Hybrid Supercapacitors.

ChemSusChem·2026
Same author

Castor Oil-Derived Ionic Liquids for Flexible, Antibacterial Biobased Thermosetting Polymers via Thiol-Ene Click Chemistry.

ACS macro letters·2025
Same author

Cellulose-Wool Keratin Composite Hydrogels as Selective Support Carriers for Gold Nanoparticles: Synthesis and Catalytic Applications in the Reduction of 4-Nitrophenol in Water.

Langmuir : the ACS journal of surfaces and colloids·2025
Same author

Synthesis Method and Principle of Octahedral Hierarchical LTA Zeolite and Its Application to Enhance Catalytic Activity in Styrene Epoxidation.

ACS omega·2024
Same author

The Engineered Lysin CF-370 Is Active Against Antibiotic-Resistant Gram-Negative Pathogens In Vitro and Synergizes With Meropenem in Experimental Pseudomonas aeruginosa Pneumonia.

The Journal of infectious diseases·2024
Same author

Introducing the Reversible Reaction of CO<sub>2</sub> with Diamines into Nonisocyanate Polyurethane Synthesis.

ACS macro letters·2023

Related Experiment Video

Updated: Jun 28, 2026

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Advances in protein therapeutics.

Gary Woodnutt1, Bernard Violand, Michael North

  • 1CovX Research, 9381 Judicial Drive, San Diego, CA 92121, USA. gwoodnutt@covx.com

Current Opinion in Drug Discovery & Development
|October 24, 2008
PubMed
Summary

This review covers new protein therapeutics, highlighting advanced platforms and successful clinical candidates. It compares these novel protein scaffolds against traditional methods, detailing their pros and cons.

Area of Science:

  • Biotechnology
  • Drug Discovery
  • Protein Engineering

Background:

  • Protein therapeutics offer targeted treatment options.
  • Traditional protein-based drugs face limitations in stability and specificity.
  • Advancements in protein engineering enable the development of novel therapeutic modalities.

Purpose of the Study:

  • To review recent progress in novel protein therapeutic discovery and development.
  • To highlight advanced technology platforms for engineering protein scaffolds.
  • To examine the clinical progression and comparative advantages of these novel agents.

Main Methods:

  • Literature review of recent scientific publications and clinical trial data.
  • Analysis of emerging protein engineering technologies and their applications.

More Related Videos

Crystallization and In Situ Room Temperature Data Collection Using the Crystallization Facility at Harwell and Beamline VMXi, Diamond Light Source
07:08

Crystallization and In Situ Room Temperature Data Collection Using the Crystallization Facility at Harwell and Beamline VMXi, Diamond Light Source

Published on: March 8, 2024

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Related Experiment Videos

Last Updated: Jun 28, 2026

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices
06:34

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Crystallization and In Situ Room Temperature Data Collection Using the Crystallization Facility at Harwell and Beamline VMXi, Diamond Light Source
07:08

Crystallization and In Situ Room Temperature Data Collection Using the Crystallization Facility at Harwell and Beamline VMXi, Diamond Light Source

Published on: March 8, 2024

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

  • Comparative assessment of novel protein scaffolds versus traditional therapeutic approaches.
  • Main Results:

    • Several advanced technology platforms are enabling the identification of novel protein therapeutic candidates.
    • Successful application of engineered protein scaffolds has led to clinical development.
    • Novel protein therapeutics demonstrate potential advantages in specificity and efficacy.

    Conclusions:

    • Novel protein scaffolds represent a promising frontier in therapeutic development.
    • Advanced platforms are accelerating the discovery and clinical translation of protein therapeutics.
    • Understanding the benefits and drawbacks is crucial for optimizing their use over traditional methods.